Ganymed’s IMAB027 Enters Phase I/II Clinical Trial for Ovarian Cancer

News   Feb 13, 2014

 
Ganymed’s IMAB027 Enters Phase I/II Clinical Trial for Ovarian Cancer
 
 
FURTHER INFORMATION
 
 
 
 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Cancer Research Cell Science Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE